• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Synthes, in silico molecular docking & pharmacokinetic studies

Bioengineer by Bioengineer
January 11, 2019
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Navin B. Patel et al. is published in Current Computer-Aided Drug Design Volume 14 , Issue 4 , 2018

IMAGE

Credit: Bentham Science Publishers, Navin B. Patel


Researchers from the Department of Chemistry, Veer Narmad South Gujarat University, India have designed and synthesized azole scaffolds (a series of A series of (E)-5-(4-((Z)-4-substitutedbenzylidene-2-thienylmethylene-5-oxo- 2-phenyl-4,5-dihydro-1H-imidazol-1-yl) benzylidene)thiazolidine-2,4-diones). Analysis of ligand-protein interactions was also conducted using molecular docking studies with (InhA) Enoyl-ACP reductase of the type II fatty acid synthase (FAS-II) system along with an investigation of the ADME properties of the scaffolds for use in oral medicine.

In vitro antimycobacterial activity was carried out against the M. tuberculosis H37Rv strain using Lowenstein-Jensen medium and antimicrobial activity against two gram-positive bacteria (S. aureus, S. pyogenes), two gram-negative bacteria (E. coli, P. aeruginosa) and three fungal species (C. albicans, A. niger, A. clavatus) using the broth microdilution method. In silico molecular docking studies were carried out using Glide (grid-based ligand docking) program incorporated in the Schrödinger molecular modeling package by Maestro 11.0 and ADME properties of synthesized compounds was performed using DruLito software.

Patel et al’s investigations revealed 6 compounds that exhibited promising antimicrobial activity and 1 compound (labelled 3n) which showed very good antimycobacterial activity along with Gilde docking score (-8.864) and with the one violation in Lipinski’s rule of five.

The researchers note that this is a preliminary result which gives directions for improving pharmaceutical derivatives for the treatment of tuberculosis. This article is Open Access. To obtain the article please visit http://www.eurekaselect.com/162197

###

Media Contact
Faizan ul Haq
[email protected]

Related Journal Article

http://dx.doi.org/10.2174/1573409914666180516113552

Tags: Atomic/Molecular/Particle PhysicsBiochemistryCell BiologyMedicine/HealthMolecular BiologyMolecular Physics
Share12Tweet8Share2ShareShareShare2

Related Posts

How Evolution Sheds Light on Autism Rates in Humans

How Evolution Sheds Light on Autism Rates in Humans

September 9, 2025
blank

Diverse Strategies Enable Fly Embryos to Resolve the Challenge of ‘Tissue Tectonic Collision’

September 9, 2025

Elephant Group Size and Age in Serengeti vs. Mikumi

September 9, 2025

Tiny Genetic Light Switches Revolutionize Disease Control

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Atomic-Level Etching Technique Enhances Hafnium Oxide, Paving the Way for Next-Generation Semiconductors

King’s College London Researcher Pioneers Advances in Psychiatric Genomics with Innovative Polygenic Scoring

Swedish Psychologist Pioneers Digital Therapy Revolution, Expanding Access to Mental Health Care

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.